1. "2017"
  2. "Molecular Pharmacology and Chemistry Program Faculty"
  3. "Michel Sadelain"
Formats
  1. Meeting Abstract (18)
  2. Journal Article (8)
Groups
  1. Center for Hematologic Malignancies (26)
  2. Department of Medicine (26)
  3. GSK Faculty (26)
  4. Hematologic Malignancies Research (26)
  5. Hematologic Malignancies, Division of (26)
  6. Molecular Pharmacology and Chemistry Program Faculty (26)

More Groups

People
  1. Michel Sadelain (26)
  2. Isabelle Riviere (14)
  3. Jae Park (8)
  4. Renier Brentjens (8)
  5. Xiuyan Wang (8)
  6. Brigitte Senechal (7)

More People

Years
  1. 2017 (26)
Publications
  1. Blood (5)
  2. Molecular Therapy (4)
  3. Journal of Clinical Oncology (3)
  4. Haematologica (2)
  5. Nature (2)
  6. Annual Review of Cancer Biology (1)

More Publications

Publishers
  1. Nature Publishing Group (8)
  2. American Society of Hematology (5)
  3. American Society of Clinical Oncology (3)
  4. Cell Press (2)
  5. Ferrata Storti Foundation (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Biomarkers associated with neurotoxicity in adult patients with relapsed or refractory B-ALL (R/R B-ALL) treated with CD19 CAR T cells
    Meeting Abstract

    Santomasso, B.; Park, J. H.; Riviere, I.; Mead, E.; Halton, E.; Diamonte, C.; Purdon, T.; Senechal, B.; Li, D.; Sadelain, M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase I trial of CD19-targeted EGFRt/19-28z/4-1BBL armored chimeric antigen receptor (CAR) modified T cells in patients with relapsed or refractory chronic lymphocytic leukemia
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X.; Senechal, B.; Bernal, Y.; Halton, E.; Diamonte, C.; Wang, Y.; Brentjens, R. J.; Sadelain, M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Durable long-term survival of adult patients with relapsed B-ALL after CD19 CAR (19-28z) T-cell therapy
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Mead, E.; Santomasso, B.; Halton, E.; Diamonte, C.; Bernal, Y.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Chimeric antigen receptors: A paradigm shift in immunotherapy
    Journal Article

    Sadelain, M.
    Annual Review of Cancer Biology (2017)

    Fulltext@MSK | Save
  • Generation of clonal antigen specific CD8αβ(+) cytotoxic T lymphocytes from renewable pluripotent stem cells for off-the-shelf T cell therapeutics
    Meeting Abstract

    Van Der Stegen, S.; Clarke, R.; Mansilla-Soto, J.; Ortiz, E.; Chang, C. W.; Sasaki, J.; Lee, T.; Lan, W.; Shoemaker, D.; Riviere, I.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Systematic combinatorial chimeric antigen receptor therapies to AML
    Meeting Abstract

    Perna, F.; Berman, S.; Soni, R. K.; Mansilla-Soto, J.; Eyquem, J.; Hamieh, M.; Hendrickson, R. C.; Brennan, C.; Sadelain, M.
    Blood (2017)

    Fulltext@MSK | Save
  • Studies of white cell, platelet, and coagulation activation with plerixafor administration in patients with sickle cell disease
    Meeting Abstract

    Pham, P.; Barbu-Stevanovic, M.; Greenberg, J.; Guarneri, D.; Mitchell, B.; Minniti, C.; Narla, M.; Yazdanbakhsh, K.; Shore, T. B.; Boulad, F.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Safety and efficacy trial of escalation of plerixafor for mobilization of CD34+ hematopoietic progenitor cells (HPCs) for globin gene transfer in patients with sickle cell disease
    Meeting Abstract

    Boulad, F.; Shore, T. B.; Van Besien, K.; Guarneri, D.; Greenberg, J.; Minniti, C.; Wiener Fedus, S.; Perna, F.; Wang, X.; Riviere, I.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Safety and efficacy trial of escalation of plerixafor for mobilization of CD34+ hematopoietic progenitor cells (HPCs) and evaluation of globin gene transfer in patients with sickle cell disease. Preliminary results
    Meeting Abstract

    Boulad, F.; Shi, P.; van Besien, K.; Guarneri, D.; Greenberg, J.; Perna, F.; Judge, A.; Sadelain, M.; Tsiporah, S.
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save